Literature DB >> 10715528

Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.

L L An1, F Rodriguez, S Harkins, J Zhang, J L Whitton.   

Abstract

Vaccines containing minigenes - isolated antigenic epitopes encoded by short open reading frames - can, under certain circumstances, confer protective immunity upon the vaccinee. Here we evaluate the efficacy of the minigene vaccine approach using DNA immunization and find that, to be immunogenic, a minigene-encoded epitope requires a perfect "Kozak" translational initiation region. In addition, using intracellular cytokine staining, we show that immunization with a plasmid encoding a full-length protein induces epitope-specific CD8(+) T cells which are detectable directly ex vivo, and constitute approximately 2% of the vaccinee's splenic CD8(+) T cells. In contrast, such cells are undetectable directly ex vivo in recipients of a minigene vaccine. Nevertheless, the minigene plasmid does induce a low number of epitope-specific CD8(+) T cells, which can be amplified to detectable levels by in vivo stimulation. Indeed, 4 days after in vivo stimulation (by virus infection), all vaccinated mice - regardless of whether they had been vaccinated with the minigene or with the full-length gene - had similar numbers of epitope-specific CD8(+) T cells. However, despite these strong responses at 4 days post-infection, recipients of the minigene vaccine showed no enhanced ability to limit virus replication and dissemination. We therefore observe a dichotomy; minigene vaccinees are not protected, despite the presence of strong virus-specific immune responses at 4 days post-challenge. We suggest that the protective benefits of vaccination exert themselves very soon - perhaps within minutes or hours - after virus challenge. If the vaccine-induced immune response is too low to achieve this early protective effect, virus-specific T cells will expand rapidly, but ineffectually, leading to the strong but non-protective response measured at 4 days post-infection. Thus, vaccine-induced immunity should be monitored very early in infection, since the extent to which these responses may later be amplified is largely irrelevant to the protection observed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715528     DOI: 10.1016/s0264-410x(99)00546-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  The signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine.

Authors:  Dimitrios Vatakis; Minnie McMillan
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity.

Authors:  Mark Yarmarkovich; John M Warrington; Alvin Farrel; John M Maris
Journal:  SSRN       Date:  2020-04-14

3.  Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors:  M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities.

Authors:  F Rodriguez; M K Slifka; S Harkins; J L Whitton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis.

Authors:  Giovanni Delogu; Amy Li; Charlene Repique; Frank Collins; Sheldon L Morris
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.

Authors:  A E Fujimura; S S Kinoshita; V L Pereira-Chioccola; M M Rodrigues
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.

Authors:  Fernando Rodriguez; Stephanie Harkins; Mark K Slifka; J Lindsay Whitton
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.

Authors:  F Rodriguez; S Harkins; J M Redwine; J M de Pereda; J L Whitton
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated salmonella typhimurium as carrier.

Authors:  Chang-Cun Guo; Jie Ding; Bo-Rong Pan; Zhao-Cai Yu; Quan-Li Han; Fan-Ping Meng; Na Liu; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 10.  Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases.

Authors:  Frances E Terry; Leonard Moise; Rebecca F Martin; Melissa Torres; Nils Pilotte; Steven A Williams; Anne S De Groot
Journal:  Expert Rev Vaccines       Date:  2014-09-05       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.